Comprehensive analysis of risk factors associating with Hepatitis B virus (HBV) reactivation in cancer patients undergoing cytotoxic chemotherapy

For cancer patients with chronic hepatitis B virus (HBV) infection, who receive cytotoxic chemotherapy, HBV reactivation is a well-described complication, which may result in varying degrees of liver damage. Several clinical features and the pre-chemotherapy HBV viral load have been suggested to be...

Descripción completa

Detalles Bibliográficos
Autores principales: Yeo, W, Zee, B, Zhong, S, Chan, P K S, Wong, W-L, Ho, W M, Lam, K C, Johnson, P J
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2004
Materias:
Clinical
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2409681/
https://www.ncbi.nlm.nih.gov/pubmed/15054446
http://dx.doi.org/10.1038/sj.bjc.6601699

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2409681/
https://www.ncbi.nlm.nih.gov/pubmed/15054446
http://dx.doi.org/10.1038/sj.bjc.6601699

Ejemplares similares